The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of exogenous interferon-gamma (IFN-gamma) on peripheral blood immune markers as part of a phase I clinical trial of combined IFN-gamma with nivolumab (Nivo) in patients (pts) with select solid tumors.
 
Matthew R. Zibelman
Research Funding - Horizon Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Horizon Pharma
 
Alexander Macfarlane
No Relationships to Disclose
 
R. Katherine Alpaugh
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - An inflammatory breast cancer cell line was established and is being provided by Fox Chase Cancer Center for research purposes. Royalities are recieved yearly dependent on the number of requests.
 
Essel Dulaimi
No Relationships to Disclose
 
Kim Costello
No Relationships to Disclose
 
John O'Neill
No Relationships to Disclose
 
Hossein Borghaei
Honoraria - Bristol-Myers Squibb; Celgene
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech; Lilly; Pfizer
Research Funding - Millennium (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech; Lilly
 
Crystal Shereen Denlinger
Consulting or Advisory Role - Lilly; Merrimack
Research Funding - Astex Pharmaceuticals (Inst); Genentech/Roche (Inst); Incyte (Inst); Lilly (Inst); MedImmune (Inst); Merrimack (Inst); OncoMed (Inst); Pfizer (Inst)
 
Daniel M. Geynisman
Consulting or Advisory Role - Novartis; Pfizer; Prometheus
Research Funding - Genentech (Inst); Merck (Inst); Millennium (Inst); Pfizer (Inst)
 
Efrat Dotan
Research Funding - Pfizer (Inst)
 
Angela Jain
Consulting or Advisory Role - Castle Biosciences
Travel, Accommodations, Expenses - Castle Biosciences
 
Lainie P. Martin
No Relationships to Disclose
 
Elias Obeid
Consulting or Advisory Role - Merck
Research Funding - Genentech/Roche (Inst); Merck; Myriad Genetics (Inst)
 
Jeffery A. Nieves
Employment - Horizon Pharma
Stock and Other Ownership Interests - Horizon Pharma
Travel, Accommodations, Expenses - Horizon Pharma
 
David Crouteau
Employment - Horizon Pharma
Stock and Other Ownership Interests - Horizon Pharma
Travel, Accommodations, Expenses - Horizon Pharma
 
Amy Y. Grahn
Employment - Horizon Pharma
Stock and Other Ownership Interests - Horizon Pharma
Travel, Accommodations, Expenses - Horizon Pharma
 
Kerry Campbell
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb; Horizon Pharma
 
Elizabeth R. Plimack
Consulting or Advisory Role - Acceleron Pharma; Bristol-Myers Squibb; Dendreon; Genentech/Roche; GlaxoSmithKline; Merck; Novartis; Pfizer
Research Funding - Acceleron Pharma (Inst); Acerta Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No.: 14/588,503, Filed 1/2/2015. (Inst)